{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:33:03Z","timestamp":1770885183152,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23fk0210104, JP23fk0210113"],"award-info":[{"award-number":["JP23fk0210104, JP23fk0210113"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Achieving sustained virologic response (SVR) in patients infected with hepatitis C virus (HCV) reduces all-cause mortality. However, the mechanisms and risk factors for liver fibrosis and portal hypertension post-SVR remain incompletely understood. In the gut-liver axis, mucosa-associated microbiota (MAM) substantially influence immune and metabolic functions, displaying spatial heterogeneity at the anatomical intestinal site. We analyzed MAM composition and function to isolate the locoregional MAM involved in chronic liver disease progression in HCV post-SVR patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We collected MAM samples from three intestinal sites (terminal ileum, ascending colon, and sigmoid colon) via brushing during colonoscopy in 23 HCV post-SVR patients and 25 individuals without liver disease (controls). The 16S rRNA of bacterial DNA in specimens collected with a brush and in feces was sequenced. The molecular expression of intestinal tissues and hepatic tissues were evaluated by quantitative real-time PCR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the post-SVR group, the microbial \u03b2-diversity of MAM, especially in the ascending colon, differed from the control group and was associated with liver fibrosis progression. In PICRUSt analysis, MAM in the ascending colon in the liver cirrhosis (LC) group showed compromised functions associated with the intestinal barrier and bile acid production, and FGF19 expression was markedly decreased in the terminal ileum biopsy tissue in the LC group. At the genus level, six short-chain fatty acid (SCFA)-producing bacterial genera, <jats:italic>Blautia<\/jats:italic>, <jats:italic>Alistipes<\/jats:italic>, <jats:italic>Roseburia<\/jats:italic>, <jats:italic>Agathobaculum<\/jats:italic>, <jats:italic>Dorea<\/jats:italic>, and <jats:italic>Pseudoflavonifractor<\/jats:italic> were reduced in the ascending colon of post-SVR LC patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In patients of HCV post-SVR, we identified the association between the degree of liver fibrosis and dysbiosis of mucosa-associated SCFA-producing bacterial genera that may be related to intestinal barrier and bile acid production in the ascending colon.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2024.1371429","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T08:59:36Z","timestamp":1712566776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Isolation of mucosa-associated microbiota dysbiosis in the ascending colon in hepatitis C virus post-sustained virologic response cirrhotic patients"],"prefix":"10.3389","volume":"14","author":[{"given":"Yohei","family":"Midori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"Nosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsushi","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Akazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsushi","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunari","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1038\/s41598-019-42059-3","article-title":"Randomized, double-blind, placebo-controlled study of a multispecies probiotic mixture in nonalcoholic fatty liver disease","volume":"9","author":"Ahn","year":"2019","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1053\/j.gastro.2015.07.029","article-title":"The FXR-FGF19 gut-liver axis as a novel \"Hepatostat\"","volume":"149","author":"Avila","year":"2015","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"G675","DOI":"10.1152\/ajpgi.00152.2012","article-title":"Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation","volume":"303","author":"Bajaj","year":"2012","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/gut.15.12.999","article-title":"Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device","volume":"15","author":"Bown","year":"1974","journal-title":"Gut"},{"key":"B6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3390\/metabo13070859","article-title":"Differences in fecal short-chain fatty acids between alcoholic fatty liver-induced cirrhosis and non-alcoholic (Metabolic-associated) fatty liver-induced cirrhosis","volume":"13","author":"Cao","year":"2023","journal-title":"Metabolites"},{"key":"B7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"14413","DOI":"10.1038\/s41598-023-41664-7","article-title":"Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection","volume":"13","author":"Chuaypen","year":"2023","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","author":"Collaborators","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/gutjnl-2017-314205","article-title":"Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota","volume":"67","author":"Ferreira","year":"2018","journal-title":"Gut"},{"key":"B11","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s12072-019-09963-2","article-title":"Bacteroides in colonic mucosa-associated microbiota affects the development of minimal hepatic encephalopathy in patients with cirrhosis","volume":"13","author":"Haraguchi","year":"2019","journal-title":"Hepatol. Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/liv.13485","article-title":"Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls","volume":"38","author":"Heidrich","year":"2018","journal-title":"Liver Int."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025042","article-title":"Pyrosequencing-based analysis of the mucosal microbiota in healthy individuals reveals ubiquitous bacterial groups and micro-heterogeneity","volume":"6","author":"Hong","year":"2011","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/hepr.13001","article-title":"Reciprocal interactions between bile acids and gut microbiota in human liver diseases","volume":"48","author":"Ikegami","year":"2018","journal-title":"Hepatol. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1080\/09168451.2016.1222267","article-title":"A preliminary investigation on the relationship between gut microbiota and gene expressions in peripheral mononuclear cells of infants with autism spectrum disorders","volume":"80","author":"Inoue","year":"2016","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/liv.14106","article-title":"Faecal microbiota from patients with cirrhosis has a low capacity to ferment non-digestible carbohydrates into short-chain fatty acids","volume":"39","author":"Jin","year":"2019","journal-title":"Liver Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1042\/BST20201201","article-title":"Relationship between mucosa-associated gut microbiota and human diseases","volume":"50","author":"Juge","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285143","article-title":"The lung microbiota in nontuberculous mycobacterial pulmonary disease","volume":"18","author":"Kim","year":"2023","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"19705","DOI":"10.1038\/s41598-021-99314-9","article-title":"Ileal mucosa-associated microbiota overgrowth associated with pathogenesis of primary biliary cholangitis","volume":"11","author":"Kitahata","year":"2021","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.jhep.2020.05.050","article-title":"Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension","volume":"73","author":"Lens","year":"2020","journal-title":"J. Hepatol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.774335","article-title":"Gut microbiota targeted approach in the management of chronic liver diseases","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(23)01320-X","article-title":"Hepatitis C","volume":"402","author":"Martinello","year":"2023","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3164\/jcbn.19-3","article-title":"Analysis of the colonic mucosa associated microbiota (MAM) using brushing samples during colonic endoscopic procedures","volume":"65","author":"Matsumoto","year":"2019","journal-title":"J. Clin. Biochem. Nutr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/aem.59.3.695-700.1993","article-title":"Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA","volume":"59","author":"Muyzer","year":"1993","journal-title":"Appl. Environ. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis","volume":"4","author":"Nakamoto","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1053\/j.gastro.2020.09.065","article-title":"Fibrosis regression after eradication of hepatitis C virus: from bench to bedside","volume":"160","author":"Rockey","year":"2021","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1987781","article-title":"The mucosally-adherent rectal microbiota contains features unique to alcohol-related cirrhosis","volume":"13","author":"Shen","year":"2021","journal-title":"Gut Microbes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000510680","article-title":"The cutting edge research of functional gastrointestinal disorders in Japan: Review on JGA core symposium 2018-2020","volume":"102","author":"Sugiyama","year":"2021","journal-title":"Digestion"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1021\/acsinfecdis.0c00432","article-title":"Alterations of the treatment-naive gut microbiome in newly diagnosed hepatitis C virus infection","volume":"7","author":"Sultan","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"9720","DOI":"10.1038\/s41598-020-66607-4","article-title":"Taxonomic and functional differences in cervical microbiome associated with cervical cancer development","volume":"10","author":"Tango","year":"2020","journal-title":"Sci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: Pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00253-010-2921-8","article-title":"Laser capture microdissection and metagenomic analysis of intact mucosa-associated microbial communities of human colon","volume":"88","author":"Wang","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/hep.31700","article-title":"Eradication of chronic HCV infection: improvement of dysbiosis only in patients without liver cirrhosis","volume":"74","author":"Wellhoner","year":"2021","journal-title":"Hepatology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1119875","article-title":"Alterations of the gut microbiota associated with the occurrence and progression of viral hepatitis","volume":"13","author":"Yang","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1099\/ijsem.0.001755","article-title":"Introducing EzBioCloud: a taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies","volume":"67","author":"Yoon","year":"2017","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ismej.2013.185","article-title":"Spatial heterogeneity and co-occurrence patterns of human mucosal-associated intestinal microbiota","volume":"8","author":"Zhang","year":"2014","journal-title":"ISME J."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1214685","article-title":"The regulatory role of bile acid microbiota in the progression of liver cirrhosis","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1371429\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T08:59:40Z","timestamp":1712566780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1371429\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":38,"alternative-id":["10.3389\/fcimb.2024.1371429"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1371429","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"article-number":"1371429"}}